Opinion - (2025) Volume 15, Issue 6
Received: 31-Oct-2025, Manuscript No. jccr-26-181165;
Editor assigned: 03-Nov-2025, Pre QC No. P-181165;
Reviewed: 17-Nov-2025, QC No. Q-181165;
Revised: 21-Nov-2025, Manuscript No. R-181165;
Published:
28-Nov-2025
, DOI: 10.37421-2165-7920.2025.15.1692
Citation: Martinez, Sofia. ”Autoimmune Encephalitis: Diagnostic Challenges and Management.” J Clin Case Rep 15 (2025):1692.
Copyright: © 2025 Martinez S. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Autoimmune encephalitis (AE) presents a complex diagnostic challenge, often mimicking infectious or neoplastic conditions. This case report details a patient experiencing progressive neurological deterioration, initially attributed to other causes. Through meticulous clinical evaluation and advanced diagnostic techniques, including autoantibody testing, a definitive diagnosis of LGI1-antibody encephalitis was established. The subContent here highlights the critical importance of considering AE in the differential diagnosis of unexplained neurological symptoms and underscores the utility of targeted autoantibody assays in achieving a prompt and accurate diagnosis [1].
This review synthesizes recent advancements in understanding the clinical spectrum and diagnostic approaches to various forms of autoimmune encephalitis, focusing on antibody-associated subtypes. It emphasizes the heterogeneity of clinical presentations, ranging from psychiatric disturbances and seizures to movement disorders and autonomic dysfunction. The article highlights the evolving role of serological testing for neural autoantibodies and discusses the diagnostic criteria, including the integration of MRI and EEG findings [2].
The diagnostic yield of cerebrospinal fluid (CSF) analysis in autoimmune encephalitis can be variable. This study investigates the utility of different CSF markers, including cell counts, protein levels, oligoclonal bands, and autoantibody detection in the CSF, for differentiating AE from other neurological conditions. The findings underscore the importance of a multi-faceted approach to CSF analysis and suggest that specific autoantibody detection in CSF remains a cornerstone for diagnosis, particularly in cases with negative serum antibody results [3].
Anti-LGI1 encephalitis is a prominent form of autoimmune encephalitis, characterized by limbic encephalitis features, seizures, and cognitive impairment. This article presents a series of cases highlighting the typical and atypical presentations of LGI1-antibody encephalitis. It discusses the diagnostic challenges encountered, including the latency of antibody detection and the potential for misdiagnosis. The emphasis is placed on early recognition and aggressive immunosuppressive treatment to improve outcomes [4].
Neuroimaging plays a crucial role in the diagnostic workup of autoimmune encephalitis, although findings can be subtle or absent in early stages. This study reviews the characteristic MRI abnormalities observed in different types of AE, including T2-hyperintensities in limbic structures, mesial temporal lobe involvement, and diffusion restriction. The article also discusses the limitations of imaging and the importance of serial imaging in detecting progressive changes [5].
This research article focuses on the therapeutic strategies for autoimmune encephalitis, emphasizing the importance of early and aggressive immunosuppression. It reviews the efficacy of first-line treatments such as corticosteroids, intravenous immunoglobulin (IVIG), and plasma exchange, as well as second-line agents like rituximab and cyclophosphamide. The article also discusses emerging therapies and the management of refractory cases, aiming to improve long-term neurological outcomes [6].
The diagnosis of autoimmune encephalitis can be challenging due to its diverse clinical manifestations and the potential for overlap with other neurological disorders. This retrospective study analyzes a cohort of patients diagnosed with AE, evaluating the diagnostic pathways, time to diagnosis, and factors influencing treatment decisions. The findings highlight common pitfalls in diagnosis and suggest strategies to expedite the diagnostic process, ultimately improving patient care [7].
This article provides an overview of the current understanding of NMDA receptor (NMDAR) antibody encephalitis, a significant cause of autoimmune limbic encephalitis, particularly in younger individuals. It describes the characteristic symptoms, including psychiatric disturbances, seizures, and movement disorders, and discusses the diagnostic approach involving NMDAR antibody testing. The review emphasizes the importance of timely diagnosis and immunotherapy for favorable outcomes [8].
The involvement of the autonomic nervous system in autoimmune encephalitis can lead to complex and challenging clinical scenarios. This study explores the spectrum of autonomic dysfunction observed in patients with various forms of autoimmune encephalitis, including orthostatic hypotension, gastrointestinal dysmotility, and thermoregulatory abnormalities. It highlights the diagnostic significance of recognizing autonomic symptoms and their potential impact on patient management and prognosis [9].
This case report details a patient with a challenging diagnosis of autoimmune encephalitis who presented with atypical symptoms and a delayed response to initial treatment. The article emphasizes the importance of a high index of suspicion for autoimmune etiologies in patients with unexplained neurological deterioration, particularly when conventional workups are unrevealing. It also discusses the evolving diagnostic criteria and the utility of advanced autoantibody testing [10].
Autoimmune encephalitis (AE) poses a significant diagnostic hurdle, often presenting with symptoms that can be mistaken for infectious or neoplastic processes. A case report illustrates this complexity, detailing a patient's progressive neurological decline that was initially misattributed. Through thorough clinical assessment and advanced diagnostic tools, including autoantibody testing, the definitive diagnosis of LGI1-antibody encephalitis was achieved, emphasizing the necessity of considering AE in the differential for unexplained neurological symptoms and the value of targeted autoantibody assays for timely and accurate diagnosis [1].
A comprehensive review synthesizes recent developments in the understanding of autoimmune encephalitis's clinical spectrum and diagnostic methods, with a particular focus on antibody-associated subtypes. The review underscores the diverse range of clinical presentations, encompassing psychiatric issues, seizures, movement disorders, and autonomic dysfunction. It highlights the increasing importance of serological tests for neural autoantibodies and outlines diagnostic criteria, integrating findings from MRI and EEG [2].
The efficacy of cerebrospinal fluid (CSF) analysis in diagnosing autoimmune encephalitis can vary. One study investigates the diagnostic utility of different CSF markers, such as cell counts, protein levels, oligoclonal bands, and autoantibody detection, to differentiate AE from other neurological conditions. The findings reinforce the need for a comprehensive CSF analysis approach, indicating that identifying specific autoantibodies in the CSF remains critical for diagnosis, especially when serum antibody tests are negative [3].
Anti-LGI1 encephalitis represents a notable form of autoimmune encephalitis, characterized by symptoms of limbic encephalitis, seizures, and cognitive deficits. An article examines a series of cases, describing both typical and atypical presentations of LGI1-antibody encephalitis and the diagnostic challenges, including delays in antibody detection and potential misdiagnosis. The importance of early identification and prompt immunosuppressive treatment for better outcomes is stressed [4].
Neuroimaging is integral to the diagnostic evaluation of autoimmune encephalitis, though findings may be subtle or absent in the early stages. Research reviews characteristic MRI abnormalities in various AE types, such as T2-hyperintensities in limbic areas, mesial temporal lobe involvement, and diffusion restriction. The study also addresses the limitations of imaging and the significance of serial scans for monitoring disease progression [5].
A research article delves into therapeutic strategies for autoimmune encephalitis, emphasizing the critical need for early and aggressive immunosuppression. It provides an overview of first-line treatments like corticosteroids, intravenous immunoglobulin (IVIG), and plasma exchange, as well as second-line options such as rituximab and cyclophosphamide. The article also touches upon novel therapies and the management of refractory cases to enhance long-term neurological recovery [6].
The diagnosis of autoimmune encephalitis can be complicated by its varied clinical presentations and overlap with other neurological disorders. A retrospective analysis of AE patients examines diagnostic pathways, time to diagnosis, and factors influencing treatment decisions. The study identifies common diagnostic errors and proposes strategies to accelerate the diagnostic process, thereby improving patient care [7].
This publication offers an overview of the current knowledge regarding NMDA receptor (NMDAR) antibody encephalitis, a primary cause of autoimmune limbic encephalitis, particularly prevalent in younger populations. It outlines the characteristic symptoms, including psychiatric disturbances, seizures, and movement disorders, and discusses the diagnostic process involving NMDAR antibody testing. The review stresses the importance of prompt diagnosis and immunotherapy for achieving positive outcomes [8].
Autonomic nervous system involvement in autoimmune encephalitis can lead to complex and challenging clinical scenarios. A study investigates the range of autonomic dysfunction observed in patients with different forms of autoimmune encephalitis, encompassing orthostatic hypotension, gastrointestinal dysmotility, and thermoregulatory abnormalities. It highlights the diagnostic value of recognizing autonomic symptoms and their potential influence on patient management and prognosis [9].
A case report describes a patient with a difficult-to-diagnose autoimmune encephalitis who presented with unusual symptoms and a delayed response to initial therapies. The article stresses the importance of maintaining a high suspicion for autoimmune causes in patients with unexplained neurological deterioration, especially when standard investigations yield no results. It also discusses the evolving diagnostic criteria and the utility of advanced autoantibody testing [10].
Autoimmune encephalitis (AE) presents a diagnostic challenge due to its varied presentations, often mimicking other neurological conditions. Key diagnostic tools include autoantibody testing in serum and cerebrospinal fluid (CSF), neuroimaging (MRI), and integration of clinical findings. Specific antibodies, such as anti-LGI1 and anti-NMDAR, are associated with distinct clinical syndromes. Autonomic dysfunction can also be a significant feature. Early and aggressive immunosuppressive treatment is crucial for improving patient outcomes. Challenges in diagnosis include atypical presentations and the need for specialized testing. Strategies to expedite diagnosis and manage refractory cases are continually evolving.
None
None
Journal of Clinical Case Reports received 1345 citations as per Google Scholar report
